Losac, a factor X activator from Lonomia obliqua bristle extract: Its role in the pathophysiological mechanisms and cell survival

Biochemical and Biophysical Research Communications

Volumn 343, Issue 4, 2006, Pages 1216-1223

  Alvarez Flores, Miryam Paola ^a   Fritzen, Márcio ^a   Reis, Cleyson V ^a   Chudzinski Tavassi, Ana Marisa ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Coagulation; Endothelial cell; Factor X activator; HUVEC; Lonomia obliqua; Losac

Indexed keywords

CALCIUM ION; DECAY ACCELERATING FACTOR; FACTOR X ACTIVATOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; NITRIC OXIDE; PROCOAGULANT; PROSTACYCLIN; PROTEIN; PROTEIN LOSAC; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; ENDOTHELIUM CELL; FUNCTIONAL PROTEOMICS; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCUBATION TIME; INSECT; ION EXCHANGE CHROMATOGRAPHY; LONOMIA OBLIQUA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMAL STRUCTURES; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; INSECT PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; MOTHS; NEOPLASM PROTEINS; NITRIC OXIDE; THROMBOPLASTIN; TISSUE EXTRACTS; VON WILLEBRAND FACTOR;

ANIMALIA; INSECTA; LONOMIA;

EID: 33646022856     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.068     Document Type: Article

References (34)

1. Kelen E.M.A., Picarelli Z.P., and Duarte A.C. Hemorrhagic syndrome induced by contact with caterpillars of the genus Lonomia (Saturniidae, Hemileucinae). J. Toxicol. Toxin. Ver. 14 (1995) 283-308
2. Zannin M., Lourenço D.M., Motta G., Dalla Costa L.R., Grando M., Gamborgi G.P., Noguti M.A., and Chudzinski-Tavassi A.M. Blood coagulation and fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by accidental contact with Lonomia obliqua caterpillar in Santa Catarina, southern Brazil. Thromb. Haemost. 89 (2003) 355-364
3. Donato J.L., Moreno R.A., Hyslop S., Duarte A., Antunes E., Le Bonniec B.F., Rendu F., and de Nucci G. Lonomia obliqua caterpillar spicules trigger human blood coagulation via activation of factor X and prothrombin. Thromb. Haemost. 79 (1998) 539-542
4. 2+ activated serine protease (LOPAP) could be responsible for the haemorrhagic syndrome caused by the caterpillar Lonomia obliqua. Lancet 353 (1999) 1942
5. Reis C.V., Portaro F.C.V., Andrade S.A., Fritzen M., Fernandes B.L., Sampaio C.A., Camargo A.C.M., and Chudzinski-Tavassi A.M. A prothrombin activator serine protease from the Lonomia obliqua caterpillar venom (Lopap). Biochemical characterization. Thromb. Res. 102 (2001) 427-436
6. Reis C.V., Farsky S.H.P., Fernandes B.L., Santoro M.L., Oliva M.L., Mariano M., and Chudzinski-Tavassi A.M. In vivo characterization of Lopap, a prothrombin activator serine protease from the Lonomia obliqua caterpillar venom. Thromb. Res. 102 (2001) 437-443
7. Lilla S., Pereira R., Hyslop S., Donato J.L., Le Bonniec B.F., and de Nucci G. Purification and initial characterization of a novel protein with factor Xa activity from Lonomia obliqua caterpillar spicules. J. Mass. Spectrom. 40 (2005) 405-412
8. Takeya H., Nishida S., Miyata T., Kawada S., Saisaka Y., Morita T., and Iwanaga S. Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J. Biol. Chem. 267 (1992) 14109-14117
9. Tans G., and Rosing J. Snake venom activators of factor X: an overview. Haemostasis 31 (2001) 225-233
10. Rhee W.J., and Park T.H. Silkworm hemolymph inhibits baculovirus-induced insect cell apoptosis. Biochem. Biophys. Res. Commun. 285 (2001) 224-228
11. Maranga L., Mendonca R.Z., Bengala A., Peixoto C.C., Moraes R.H.P., Pereira C.A., and Carrondo M.J.T. Enhancement of Sf-9 cell growth and longevity through supplementation of culture medium with hemolymph. Biotechnol. Prog. 19 (2003) 58-63
12. Souza A.P., Peixoto C.C., Maranga L., Carvalhal A.V., Moraes R.H., Mendonça R.M., Pereira C.A., Carrondo M.J., and Mendonça R.Z. Purification and characterization of an anti-apoptotic protein isolated from Lonomia obliqua hemolymph. Biotechnol. Prog. 21 (2005) 99-105
13. Chudzinski-Tavassi A.M., Schattner M., Fritzen M., Pozner R.G., Reis C.V., Lourenço D., and Lazzari M.A. Effects of Lopap on human endothelial cells and platelets. Haemostasis 31 (2001) 257-265
14. Fritzen M., Flores M.P.A., Reis C.V., and Chudzinski-Tavassi A.M. A prothrombin activator (Lopap) modulating inflammation, coagulation and cell survival mechanism. Biochem. Biophys. Res. Commun. 333 (2005) 517-523
15. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973) 2745-2756
16. Dandona P. Endothelium, inflammation, and diabetes. Curr. Diab. Resp. 2 (2002) 311-315
17. Ziche M., and Morbidelli L. Nitric oxide and angiogenesis. J. Neurooncol. 50 (2000) 139-148
18. Cooke J.P. NO and angiogenesis. Atheroscler. Suppl. 4 (2003) 53-60
19. Kim P.K.M., Kwon Y.G., Chung H.T., and Kim Y.M. Regulation of caspases by nitric oxide. Ann. N.Y. Acad. Sci. 962 (2002) 42-52
20. van de Stolpe A., and van der Saag P.T. Intercellular adhesion molecule-1. J. Mol. Med. 74 (1996) 13-33
21. Lublin D.M., and Atkinson J.P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7 (1989) 35-58
22. Lowenstein C.J., Morrel C.N., and Yamacuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc. Med. 15 (2005) 302-308
23. Huber D., Cramer E.M., Kaufmann J.E., Meda P., Massé J.M., Kruithof E.K.O., and Vischer U.M. Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and vivo. Blood 99 (2002) 3637-3645
24. Wagner D.D., Olmsted J.B., and Marder V.J. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J. Cell. Biol. 95 (1982) 355-360
25. Steffel J., Luscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implication. Circulation 113 (2006) 722-731
26. Markland F.S. Snake venoms and the hemostatic system. Toxicon 36 (1998) 1749-1800
27. Kucharewicz I., Kowal K., Buczko W., and Bodzenta-Lukaszyk A. The plasmin system in airway remodelling. Thromb. Res. 112 (2003) 1-7
28. Yasunaga C., Nakashima Y., and Sueishi K. A role of fibrinolytic activity in angiogenesis. Lab. Invest. 61 (1989) 698
29. Welling T.H., Huber T.S., Messina L.M., and Stanley J.C. Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism. J. Surg. Res. 66 (1996) 36-42
30. Utgaard J.O., Jahnsen F.L., Bakka A., Brandtzaeg P., and Haraldsen G. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J. Exp. Med. 188 (1998) 1751-1756
31. Kirchhofer D., Lipari M.T., Moran P., Eigenbrot C., and Kelley R.F. The tissue factor region that interacts with substrates factor IX and factor X. Biochemistry 39 (2000) 7380-7387
32. Rosnoblet C., Vischer U.M., Gerard R.D., Irminger J.C., Halban P.A., and Kruithof E.K. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1796-1803
33. Emeis J.J., van den Eijnden-Schrauwen Y., van den Hoogen C.M., de Priester W., Wesmuckett A., and Lupu F. An endothelial storage granule for tissue-type plasminogen activator. J. Cell. Biol. 139 (1997) 245-256
34. Pinto A.F., Silva K.R., and Guimaraes J.A. Proteases from Lonomia obliqua venomous secretions: comparison of procoagulant, fibrin(ogen)olytic and amidolytic activities. Toxicon 47 (2006) 113-121